Immunomodulatory role of histamine H4 receptor in breast cancer
- Autores
- Sterle, Helena Andrea; Nicoud, Melisa Beatriz; Massari, Noelia Andrea; Táquez Delgado, Mónica Alejandra; Herrero Ducloux, María Verónica; Cremaschi, Graciela Alicia; Medina, Vanina Araceli
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. Methods: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. Results: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4 + tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19 + lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4 + T cells and T regulatory cells (CD4 + CD25 + FoxP3 + ), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4 + , CD19 + and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. Conclusions: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment.
Fil: Sterle, Helena Andrea. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina
Fil: Nicoud, Melisa Beatriz. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina
Fil: Massari, Noelia Andrea. Universidad Nacional de la Patagonia "San Juan Bosco". Facultad de Ciencias Naturales - Sede Comodoro; Argentina
Fil: Táquez Delgado, Mónica Alejandra. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina
Fil: Herrero Ducloux, María Verónica. Universidad Nacional de la Patagonia "San Juan Bosco". Facultad de Ciencias Naturales - Sede Comodoro; Argentina
Fil: Cremaschi, Graciela Alicia. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina
Fil: Medina, Vanina Araceli. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina - Materia
-
Histamine H4 receptor
Breast Cancer
antitumor immunity - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/120495
Ver los metadatos del registro completo
id |
CONICETDig_23d2f5d7b77bfc02e6b0668904c11371 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/120495 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Immunomodulatory role of histamine H4 receptor in breast cancerSterle, Helena AndreaNicoud, Melisa BeatrizMassari, Noelia AndreaTáquez Delgado, Mónica AlejandraHerrero Ducloux, María VerónicaCremaschi, Graciela AliciaMedina, Vanina AraceliHistamine H4 receptorBreast Cancerantitumor immunityhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Background: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. Methods: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. Results: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4 + tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19 + lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4 + T cells and T regulatory cells (CD4 + CD25 + FoxP3 + ), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4 + , CD19 + and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. Conclusions: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment.Fil: Sterle, Helena Andrea. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Nicoud, Melisa Beatriz. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Massari, Noelia Andrea. Universidad Nacional de la Patagonia "San Juan Bosco". Facultad de Ciencias Naturales - Sede Comodoro; ArgentinaFil: Táquez Delgado, Mónica Alejandra. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Herrero Ducloux, María Verónica. Universidad Nacional de la Patagonia "San Juan Bosco". Facultad de Ciencias Naturales - Sede Comodoro; ArgentinaFil: Cremaschi, Graciela Alicia. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Medina, Vanina Araceli. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaNature Publishing Group2019-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/120495Sterle, Helena Andrea; Nicoud, Melisa Beatriz; Massari, Noelia Andrea; Táquez Delgado, Mónica Alejandra; Herrero Ducloux, María Verónica; et al.; Immunomodulatory role of histamine H4 receptor in breast cancer; Nature Publishing Group; British Journal Of Cancer; 120; 1; 1-2019; 128-1380007-0920CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://www.nature.com/articles/s41416-018-0173-zinfo:eu-repo/semantics/altIdentifier/doi/10.1038/s41416-018-0173-zinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-17T10:52:31Zoai:ri.conicet.gov.ar:11336/120495instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-17 10:52:31.65CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title |
Immunomodulatory role of histamine H4 receptor in breast cancer |
spellingShingle |
Immunomodulatory role of histamine H4 receptor in breast cancer Sterle, Helena Andrea Histamine H4 receptor Breast Cancer antitumor immunity |
title_short |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_full |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_fullStr |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_full_unstemmed |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_sort |
Immunomodulatory role of histamine H4 receptor in breast cancer |
dc.creator.none.fl_str_mv |
Sterle, Helena Andrea Nicoud, Melisa Beatriz Massari, Noelia Andrea Táquez Delgado, Mónica Alejandra Herrero Ducloux, María Verónica Cremaschi, Graciela Alicia Medina, Vanina Araceli |
author |
Sterle, Helena Andrea |
author_facet |
Sterle, Helena Andrea Nicoud, Melisa Beatriz Massari, Noelia Andrea Táquez Delgado, Mónica Alejandra Herrero Ducloux, María Verónica Cremaschi, Graciela Alicia Medina, Vanina Araceli |
author_role |
author |
author2 |
Nicoud, Melisa Beatriz Massari, Noelia Andrea Táquez Delgado, Mónica Alejandra Herrero Ducloux, María Verónica Cremaschi, Graciela Alicia Medina, Vanina Araceli |
author2_role |
author author author author author author |
dc.subject.none.fl_str_mv |
Histamine H4 receptor Breast Cancer antitumor immunity |
topic |
Histamine H4 receptor Breast Cancer antitumor immunity |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. Methods: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. Results: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4 + tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19 + lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4 + T cells and T regulatory cells (CD4 + CD25 + FoxP3 + ), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4 + , CD19 + and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. Conclusions: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment. Fil: Sterle, Helena Andrea. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina Fil: Nicoud, Melisa Beatriz. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina Fil: Massari, Noelia Andrea. Universidad Nacional de la Patagonia "San Juan Bosco". Facultad de Ciencias Naturales - Sede Comodoro; Argentina Fil: Táquez Delgado, Mónica Alejandra. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina Fil: Herrero Ducloux, María Verónica. Universidad Nacional de la Patagonia "San Juan Bosco". Facultad de Ciencias Naturales - Sede Comodoro; Argentina Fil: Cremaschi, Graciela Alicia. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina Fil: Medina, Vanina Araceli. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina |
description |
Background: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. Methods: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. Results: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4 + tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19 + lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4 + T cells and T regulatory cells (CD4 + CD25 + FoxP3 + ), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4 + , CD19 + and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. Conclusions: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/120495 Sterle, Helena Andrea; Nicoud, Melisa Beatriz; Massari, Noelia Andrea; Táquez Delgado, Mónica Alejandra; Herrero Ducloux, María Verónica; et al.; Immunomodulatory role of histamine H4 receptor in breast cancer; Nature Publishing Group; British Journal Of Cancer; 120; 1; 1-2019; 128-138 0007-0920 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/120495 |
identifier_str_mv |
Sterle, Helena Andrea; Nicoud, Melisa Beatriz; Massari, Noelia Andrea; Táquez Delgado, Mónica Alejandra; Herrero Ducloux, María Verónica; et al.; Immunomodulatory role of histamine H4 receptor in breast cancer; Nature Publishing Group; British Journal Of Cancer; 120; 1; 1-2019; 128-138 0007-0920 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.nature.com/articles/s41416-018-0173-z info:eu-repo/semantics/altIdentifier/doi/10.1038/s41416-018-0173-z |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Nature Publishing Group |
publisher.none.fl_str_mv |
Nature Publishing Group |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1843606158996144128 |
score |
13.000565 |